Leaderboard

En | De
Sie sind hier: Urologie-Nephrologie 16. Juli 2026
Suchen
medline.ch
Urologie-Nephrologie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Entzündung-Infekt
Nephrolithiasis
Niereninsuffizienz
Sexualität
Tumoren/BPH
Anderes
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 23845  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 476885  
   
Evaluation of two inactivated vaccines against Campylobacter fetus in an experimental bovine model: immunological survey and genital clearance in heifers.
Braz J Microbiol
García JA, Cagnoli CI, Sardi F, Miqueo E, Rodríguez M, Morsella C, Mendez A, Cacciato C, Chiapparrone ML, Barale J, Azaldegui I, Nieto V, Barrandeguy N, Alonzo P, Paolicchi F.
PMID: 42458123 [PubMed - in process]


External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection.
Eur J Nucl Med Mol Imaging
Schmidt CJ, Gaertner FC, Kreppel B, Essler M, Luetkens JA, Attenberger U, Anspach M, Ohlmann CH, Bernhardt M, Kristiansen G, Hauser S, Ellinger J, Ritter M, Krausewitz P.
PMID: 42458057 [PubMed - as supplied by publisher]


Letter to the Editor: Diagnostic assessment of artificial intelligence reconstruction on accelerated prostate MRI: a retrospective, paired, multireader multi-case study.
Eur Radiol
Wang Z, Yu C.
PMID: 42458056 [PubMed - as supplied by publisher]


Oscars' inclusion standards for kidney trials.
Nat Rev Nephrol
Krishnasamy R.
PMID: 42457885 [PubMed - as supplied by publisher]


Long-term outcomes of real-time TRUS-guided HDR brachytherapy monotherapy for low and favorable intermediate-risk prostate cancer and predictive value of PSA nadir.
Brachytherapy
Gaztañaga M, Escribano C, Montero B, de Areba J, Martínez DF, Galante I, Serrano-Garcia I, Vázquez MG.
PMID: 42457607 [PubMed - as supplied by publisher]


Robot-assisted Renal Auto Transplantation: State of the Art.
Eur Urol Focus
Di Bello F, Territo A, Gallioli A, Rodriguez-Faba Ó, Gaya JM, Belarmino AR, Avesani G, Graps G, Pecoraro A, Lopez-Abad A, Dönmez MI, Polat ME, Decaestecker K, Campi R, Masieri L, Serni S, Palou J, Breda A, Eurpoean Association of Urology (EAU) Robotic Urology Section (ERUS) and EAU - YAU Kidney Transplant Working Group.
PMID: 42457484 [PubMed - as supplied by publisher]


Re: Manuel Ritter, Johannes Stein, Neil Barber, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-274.
Eur Urol Focus
Schwartzmann I, Silvestri D.
PMID: 42457483 [PubMed - as supplied by publisher]


ARALU - Phase 2, Open-label, Randomized Study to Investigate Safety and Efficacy of Pluvicto Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer in Addition to Standard of Care Treatment with Nubeqa and ADT.
Eur Urol Focus
Franz J, Brumberg J, Mix M, Meyer PT, Herrmann K, Gratzke C, Sigle A.
PMID: 42457482 [PubMed - as supplied by publisher]


Novel BCG Combination or Modified BCG Regimens in BCG-Naïve High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
Eur Urol Focus
Pattou M, Rouprêt M, Kamat A, Boorjian SA, Gontero P, Shariat SF, D'Andrea D.
PMID: 42457481 [PubMed - as supplied by publisher]


Bacterial Vaccines for Recurrent Urinary Tract Infections: A Systematic Review with Emerging Evidence in Kidney Transplant Recipients.
Eur Urol Focus
Bitar N, Howell G, He M, Zakri R.
PMID: 42457478 [PubMed - as supplied by publisher]


Re: [177Lu]-PSMA-617-PSMA-617 in Oligometastatic Hormone Sensitive Prostate Cancer (BULLSEYE): An Open-label, Randomised, Phase 2 Study.
Eur Urol
Belliveau C, Kishan AU, Calais J, Plouznikoff N, Ménard C.
PMID: 42457458 [PubMed - as supplied by publisher]


Re: Testosterone Treatment in Prostate Cancer Survivors with Hypogonadism: A Randomized Clinical Trial.
Eur Urol
O'Callaghan ME, Selth L, Wittert G.
PMID: 42457457 [PubMed - as supplied by publisher]


EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
Eur Urol
Cornford P, van den Bergh RCN, Briers E, Chiu P, Eberli D, Epure A, Farolfi A, Fonteyne V, Gandaglia G, Gillessen S, Grivas N, Henry AM, van Leenders GJLH, Espinos EL, Matsen B, Oldenburg J, van Oort IM, Oprea-Lager DE, Roberts MJ, Rouvière O, Sachdeva A, Santis M, Schoots IG, Smith EJ, Stranne J, Wiegel T, Tilki D.
PMID: 42457454 [PubMed - as supplied by publisher]


European Association of Urology Guidelines on Urological Infections: Summary of the 2026 Guidelines.
Eur Urol
Kranz J, Cai T, Geerlings S, Köves B, Lambregts MMC, Mantica G, Pilatz A, Medina-Polo J, Schneidewind L, Schubert S, Vallée M, Veeratterapillay R, Wagenlehner F, Bausch K, Devlies W, Leitner L, Stangl F, Ali H, Smith EJ, Bonkat G.
PMID: 42457453 [PubMed - as supplied by publisher]


European Association of Urology Guidelines on Neuro-urology: Summary of the 2026 Update.
Eur Urol
Sartori AM, Kessler TM, Ecclestone H, Frings D, Gallo ML, Gross O, Hamid R, Hentzen C, Karsenty G, Musco S, Padilla-Fernández B, Panicker JN, de Keijzer P, van der Vorm A, Schouten N, Blok BFM.
PMID: 42457452 [PubMed - as supplied by publisher]


Association of Roxadustat Versus Erythropoiesis-Stimulating Agents With Renal Outcomes in Non-Dialysis CKD: A Propensity-Matched Real-World Cohort Study.
Clin Ther
Ouyang Y, Ren H, Zhu L, Wu Y, Wang Y, Fu X, Li X, Wang W, Cen J, Xie J, Chen N.
PMID: 42457444 [PubMed - as supplied by publisher]


Renal injury and hypocalcaemia in newborns with birth asphyxia at a tertiary care centre: a prospective observational study.
BMJ Paediatr Open
Tard SC, Tanwar GS, Berwal PK.
PMID: 42457390 [PubMed - in process]


"Testicular concentrations of metals and metalloids in dogs from the 'Land of Fires' (Campania Region, Italy): a preliminary morphological, chemical and molecular study".
Environ Toxicol Pharmacol
Riccio L, De Falco M, Trifuoggi M, Cucolo C, Conte F, Chianese T, Ambrosio N, Spada A, Di Napoli E, Paciello O, Rosati L.
PMID: 42456842 [PubMed - as supplied by publisher]


Reply to Editorial Comment on 'Through the Eyes of the Applicant: A Qualitative Study of the Urology Residency Match'.
Urology
Hunt TC, Siodis GK, Quarrier SO, Rashid HH.
PMID: 42456779 [PubMed - as supplied by publisher]


Quantitative assessment of additive effects of mirabegron and solifenacin in overactive bladder: re-analysis of SYNERGY study.
Urology
Chen W, Yoshida S, Yajima S, Fukushima H, Sato H, Hirakawa A, Yamamoto T, Honda H, Matsuo T, Wada N, Masuda H, Fujii Y.
PMID: 42456778 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 476885    Seite 1 von 23845  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1